Clinicopathological and genetic study in cerebral aspergillosis and leukemic infitration in ALL

Journal of Pediatric Neurology

Volumn 2, Issue 1, 2004, Pages 39-43

  Kumar, Raj ^a   Singh, Vinita ^a   Vaish, Minal ^a   Pal, Lily ^a   Mittal, Balraj ^a  

^a SANJAY GANDHI POSTGRADUATE INSTITUTE OF MEDICAL SCIENCES   (India)

Author keywords

Central nervous system; Fungal granuloma; Fungal infections; Leukemic brain infiltration; Microsatellite instability

Indexed keywords

EID: 85013579441     PISSN: 13042580     EISSN: 13050613     Source Type: Journal    
DOI: None     Document Type: Article

References (26)

1. Goodman ML, Coffey RJ. Streotactic drainage of aspergillus brain abscess with long-term survival: case report and review. Neurosurgery 1989; 24: 96-99.
2. Alvino E, Fernandez E, Pallini R. Microsatellite instability in primary brain tumors. Neurol Res 2000; 22: 571-575.
3. Spens N, Tattersall WH. Fungal infection of the central nervous system supervening during routine chemotherapy for pulmonary tuberculosis. Br Med J 1965; 5466: 862.
4. Klein HJ, Richter HP, Schachenmayr W. Intracerebral aspergillus abscess: case report. Neurosurgery 1983; 13: 306-309.
5. Kasantikul V, Shuangshoti S, Taecholarn C. Primary phycomycosis of the brain in heroin addicts. Surg Neurol 1987; 28: 468-472.
6. Kim DG. Hong SC, Kim HJ, et al. Cerebral aspergillosis in immunologically competent adults. Surg Neurol 1993; 40: 326-331.
7. Yamamoto N, Miyara T, Kawakami K, et al. A case of disseminated aspergillosis with smoldering adult T-cell leukemia. Kansenshogaku Zasshi 2002; 76: 460-465 (in Japanese).
8. Lin Zy, Sheng RY, Li XL, Li TS, Wang AX. Nosocomial fungal infections, analysis of 149 cases. Zhonghua Yi Xne Za Zhi 2003; 83: 399-402 (in Chinese).
9. Erdoğan E, Beyzadeoğlu M, Arpacı F, Celasun B. Cerebellar aspergillosis: case report and literature review. Neurosurgery 2002; 50: 874-876.
10. Hay RJ. Fungal infections. Med Int (Middle Eastern Edition) 1998; 53: 2203-2209.
11. Sharma RR, Gurusinghe NT, Lynch PG. Cerebral infarction due to Aspergillus arteritis following glioma surgery. Br J Neurosurg 1992; 6: 485-490.
12. Darras-Joly C, Veber B, Bedos JP, Gachot B, Regnier B, Wolff M. Nosocomial cerebral aspergillosis: a report of 3 cases. Scand J Infect Dis 1996; 28: 317-319.
13. Cohen J. Clinical manifestations and management of aspergillosis in the compromised patients. In: Warnock DW, Richardson MD (eds). Fungal Infection in the Compromised Patients. Chichester: John Wiley Sons, 1991, pp 117-151.
14. Denning DW, Stevens DA. Antifungal and surgical treatment of invasive aspergillosis: review of 2,121 published cases. Rev Infect Dis 1990; 12: 1147-1201.
15. Meyer D, Young LS, Armstrong D, Yu B. Aspergillosis complicating neoplastic disease. Am J Med 1973; 54: 6-15.
16. Lyons RW, Andriole VT. Fungal infections of the CNS. Neurol Clin 1986; 4: 159-170.
17. Armstrong D, Wong B. Central nervous system infection in immunocompromised hosts. Annu Rev Med 1982; 33: 293-308.
18. Fisher BD, Asmstrong D, Yu B, Gold JW. Invasive aspergillosis: progress in early diagnosis and treatment. Am J Med 1981; 71: 571-577.
19. Miaux Y, Ribaund P, Williams M, et al. MR of cerebral aspergillosis in patients who have had bone marrow transplantation. AJNR Am J Neuroradiol 1995; 16: 555-562.
20. Cox J, Murtagh FR, Wilfong A, Brenner J. Cerebral aspergillosis: MR imaging and histopathologic correlation. AJNR Am J Neuroradiol 1992; 13: 1489-1492.
21. Kanerva J, Niini T, Vettenranta K, et al. Loss at 12p detected by comparative genomic hybridization (CGH): association with TEL-AML1 fusion and favorable prognostic features in childhood acute lymphoblastic leukemia (ALL). A multi-institutional study. Med Pediatr Oncol 2001; 37: 419-425.
22. Morison IM, Ellis LM, Teague LR, Reeve AE. Preferential loss of maternal 9p alleles in childhood acute lymphoblastic leukemia. Blood 2002; 99: 375-377.
23. McEvoy CR, Morley AA, Firgaira FA. Evidence for whole chromosome 6 loss and duplication of the remaining chromosome in acute lymphoblastic leukemia. Genes Chromosomes Cancer 2003; 37: 321-325.
24. Bertin R, Acquaviva C, Mirebeau D, Guidal-Giroux C, Vilmer E, Cave H. CDKN2A, CDKN2B, and MTAP gene dosage permits precise characterization of mono-and bi-allelic 9p21 deletions in childhood acute lymphoblastic leukemia. Genes Chromosomes Cancer 2003; 37: 44-57.
25. Andreasson P, Hoglund M, Bekassy AN, et al. Cytogenetic and FISH studies of a single center consecutive series of 152 childhood acute lymphoblastic leukemias. Eur J Haematol 2000; 65: 40-51.
26. Takeuchi S, Tsukasaki K, Bartram CR, et al. Long-term study of the clinical significance of loss of heterozygosity in childhood acute lymphoblastic leukemia. Leukemia 2003; 17: 149-154.